The mission of Grove Nanomaterials Limited is to deploy highly innovative, sustainable manufacturing processes to produce nanomaterials for medical diagnostics with enhanced performance and with lower cost and reduced negative impact on environment and health/safety. An example is the production of colloidal (nano) gold which is a carrier and visualisation agent in diagnostics for both infectious disease and food allergen, e.g. it forms the red lines in a Covid home test. Grove is a spin-out from Swansea University which has assigned 3 patents.